Skip to Main Content (Press Enter)

Logo UNISR
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills
  • Equipment

UNIFIND
Logo UNISR

|

UNIFIND

unisr.it
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills
  • Equipment
  1. Outputs

Antiangiogenic agents after first line and sorafenib plus chemoembolization: A systematic review

Academic Article
Publication Date:
2017
Short description:
Antiangiogenic agents after first line and sorafenib plus chemoembolization: A systematic review / Casadei Gardini, A., Santini, D., Aprile, G., Silvestris, N., Felli, E., Foschi, F.G., Ercolani, G., Marisi, G., Valgiusti, M., Passardi, A., Puzzoni, M., Silletta, M., Brunetti, O., Cardellino, G.G., Frassineti, G.L., Scartozzi, M.. - In: ONCOTARGET. - ISSN 1949-2553. - 8:(2017), pp. 66699-66708. [10.18632/oncotarget.19449]
abstract:
Transarterial chemoembolization (TACE) is the standard treatment for intermediate stage, although the combination of TACE with sorafenib may theoretically benefit HCC patients in intermediate stage. Owing to the significant antiangiogenic effect of sorafenib and the limitation of TACE, it is rational to combine them. Though the strategy of combining TACE and sorafenib has been increasingly used in patients with unresectable HCC but the current evidence is controversial and its clinical role has not been determined yet. In first-line therapy, patients receiving sorafenib had increased overall survival and progression free survival. Therefore several antiangiogenic agents have entered clinical studies on HCC, many with negative results. This review discusses the current drug development for patients with HCC and role of TACE plus sorafenib.
Iris type:
1.1 Articolo in rivista
Keywords:
Antiangiogenic; Hepatocellular carcinoma; Second line; Tace; Transcatheter arterial chemoembolization; Oncology
List of contributors:
Casadei Gardini, Andrea; Santini, Daniele; Aprile, Giuseppe; Silvestris, Nicola; Felli, Emanuele; Foschi, Francesco Giuseppe; Ercolani, Giorgio; Marisi, Giorgia; Valgiusti, Martina; Passardi, Alessandro; Puzzoni, Marco; Silletta, Marianna; Brunetti, Oronzo; Cardellino, Giovanni Gerardo; Frassineti, Giovanni Luca; Scartozzi, Mario
Authors of the University:
CASADEI GARDINI ANDREA
Handle:
https://iris.unisr.it/handle/20.500.11768/104103
Published in:
ONCOTARGET
Journal
  • Overview

Overview

URL

http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=download&path[]=19449&path[]=62192
  • Use of cookies

Powered by VIVO | Designed by Cineca | 26.11.1.0